Stay updated on Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed mentions of 'Multiple myeloma' and related topics such as 'MedlinePlus Genetics'.
    Difference
    0.1%
    Check dated 2026-02-22T05:42:59.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision: v3.4.2 deployed, replacing v3.4.1. No user-facing content or study data appear to have changed.
    Difference
    0.0%
    Check dated 2026-02-14T15:29:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    19 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1 and related topics (Multiple Myeloma; MedlinePlus Genetics) were added. No changes to core study content, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-02-05T22:26:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added the disease tag 'Multiple myeloma' and a link to related topics (MedlinePlus Genetics) as metadata enhancements that aid navigation without altering trial information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-22T09:16:23.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The site shows a minor version revision from v3.3.3 to v3.3.4, with no changes to study details, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:32:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now lists additional trial locations across Arkansas, Florida, Georgia, Illinois, Iowa, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Nebraska, New Jersey, New York, North Carolina, Oregon, South Carolina, Texas, Virginia, and the Canadian provinces Alberta, British Columbia, Nova Scotia, Ontario, and Quebec. It also shows a page revision tag (Revision: v3.3.3).
    Difference
    1%
    Check dated 2025-12-24T14:55:03.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.